T. Damci Et Al. , "Orlistat augments postprandial increases in glucagon-like peptide-1 in obese type 2 diabetic patients - Response to Horowitz et al.," DIABETES CARE , vol.27, no.11, pp.2771, 2004
Damci, T. Et Al. 2004. Orlistat augments postprandial increases in glucagon-like peptide-1 in obese type 2 diabetic patients - Response to Horowitz et al.. DIABETES CARE , vol.27, no.11 , 2771.
Damci, T., YALIN, S., Balci, H., Osar, Z., KORUGAN, Ü., ÖZYAZAR, M., ... Ilkova, H. M.(2004). Orlistat augments postprandial increases in glucagon-like peptide-1 in obese type 2 diabetic patients - Response to Horowitz et al.. DIABETES CARE , vol.27, no.11, 2771.
Damci, Taner Et Al. "Orlistat augments postprandial increases in glucagon-like peptide-1 in obese type 2 diabetic patients - Response to Horowitz et al.," DIABETES CARE , vol.27, no.11, 2771, 2004
Damci, Taner Et Al. "Orlistat augments postprandial increases in glucagon-like peptide-1 in obese type 2 diabetic patients - Response to Horowitz et al.." DIABETES CARE , vol.27, no.11, pp.2771, 2004
Damci, T. Et Al. (2004) . "Orlistat augments postprandial increases in glucagon-like peptide-1 in obese type 2 diabetic patients - Response to Horowitz et al.." DIABETES CARE , vol.27, no.11, p.2771.
@article{article, author={Taner DAMCI Et Al. }, title={Orlistat augments postprandial increases in glucagon-like peptide-1 in obese type 2 diabetic patients - Response to Horowitz et al.}, journal={DIABETES CARE}, year=2004, pages={2771} }